NextCure, Inc. Common Stock (NXTC) is a publicly traded Healthcare sector company. As of July 14, 2026, NXTC trades at $8.70 with a market cap of $7.12M and a P/E ratio of -0.11. NXTC moved +311.01% today. Year to date, NXTC is -84.41%; over the trailing twelve months it is -54.01%. Its 52-week range spans $1.55 to $16.56. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces NXTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for NXTC shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $8.70 |
| Market Cap | $7.12M |
| P/E Ratio | -0.11 |
| EPS | $-19.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.56 |
| 52-Week Low | $1.55 |
| Volume | 55.75M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-55.84M |
| Gross Margin | 0.00% |
2 analysts cover NXTC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.